Join Srigowri Kota, MSN, BA, APN, AGNP-C, AOCNP, for an in-depth webinar on the management and toxicity considerations for patients receiving antibody-drug conjugate (ADC) therapy.

This course covers the basics of cancer biology and genetics, including cancer characteristics, carcinogenesis, oncogenes, tumor suppressor genes, and cellular signaling pathways. It also addresses genetic testing for hereditary cancer syndromes and tumor genomic profiling, with insights into future developments, report information, and somatic variant–drug pairs.

Tune in to stay updated with the latest advancements in hematology, oncology from the ASCO 2024 conference, and FDA drug approvals.

Join Amber B. Clemmons, PharmD, BCOP, FHOPA, for an informative webinar on antibody-drug conjugate (ADC) molecular design principles.

Join Cara Norelli and Megan Bielawa, advanced practice providers who specialize in oncodermatology, to gain critical insights into managing dermatologic toxicities from cancer therapies. This webinar will equip you with the skills to recognize toxicities and understand the impact on patient well-being and treatment adherence and implement evidence-based prevention and management strategies.